Bio-Rad Laboratories (BIO) Cash from Operations (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Cash from Operations data on file, last reported at 108100000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations fell 16.78% year-over-year to 108100000.0 in Q1 2026; TTM through Mar 2026 was 510400000.0, a 0.95% decrease from a year earlier, with the FY2025 full-year figure at 532200000.0, up 16.92% from the prior year.
• Cash from Operations for Q1 2026 stood at 108100000.0, down from 164900000.0 in the prior quarter.
• Over the last five years, Cash from Operations for BIO reached as high as 164900000.0 in Q4 2025 and fell as low as 10990000.0 in Q3 2022.
• Historically, Cash from Operations has averaged 97929411.76 across 5 years, with a median of 98081000.0 in 2023.
• Across the five-year window, Cash from Operations slumped 95.23% in 2022 and surged 788.95% in 2023, its largest moves.
• Year by year, Cash from Operations stood at 79610000.0 in 2022, then rose by 1.75% to 81004000.0 in 2023, then jumped by 53.33% to 124200000.0 in 2024, then jumped by 32.77% to 164900000.0 in 2025, then sank by 34.45% to 108100000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 108100000.0 in Q1 2026, 164900000.0 in Q4 2025, and 120900000.0 in Q3 2025.